Israa H Al-Ani (Israa Al-Ani)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Capillary Electrophoresis

Small Cell Lung Cancer

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Bashar J M Majeed, Mohammed A Saadallah, Israa H Al-Ani, Mohamed K El-Tanani, Khaldun M A Azzam, Hassan H Abdallah, Feras Darwish Elhajji
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Dheyaa Tohma Madlool, Israa H Al-Ani, Tha'er Ata, Wael Abu Dayyih
Solubility, pH-Solubility Profile, pH-Rate Profile, and Kinetic Stability of the Tyrosine Kinase Inhibitor, Alectinib. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Bashar J M Majeed, Mohammed A Saadallah, Israa H Al-Ani, Mohamed K El-Tanani, Khaldun M A Azzam, Hassan H Abdallah, Feras Darwish Elhajji
Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Dheyaa Tohma Madlool, Israa H Al-Ani, Tha'er Ata, Wael Abu Dayyih
Solubility, pH-Solubility Profile, pH-Rate Profile, and Kinetic Stability of the Tyrosine Kinase Inhibitor, Alectinib. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)